Expect a clash at today’s FDA peptide panel
An FDA panel convenes to debate regulatory changes that would allow compounding pharmacies to manufacture certain peptides, amid surging but largely unregulated peptide use among Americans.
An FDA panel convenes to debate regulatory changes that would allow compounding pharmacies to manufacture certain peptides, amid surging but largely unregulated peptide use among Americans.
An inquiry examining deaths of over 2,000 mental health patients in Essex found no strong independent evidence that Oxevision monitoring technology improves patient safety.
The Senate Health Committee advanced a bill banning junk food ads to children and requiring FDA warning labels on ultra-processed foods high in sugar, salt, and saturated fat.
UK healthy life expectancy has fallen to its lowest level since 2011, with Britons now living about a quarter of their lives in poor health, raising questions about NHS effectiveness.
Vaccinated women now have an almost zero chance of dying from cervical cancer before age 30, raising questions about whether cervical screening remains necessary.
Canadian psychologist Candice Odgers challenges the prevailing narrative that social media bans are the best solution to online harms for teenagers, citing mixed research evidence and arguing that multiple factors drive adolescent mental health crises.